(Reuters) - NEW YORK, July 17 - Johnson & Johnson on Tuesday said second-quarter profit rose on higher sales of medical devices and prescription drugs, beating Wall Street expectations on especially strong demand in overseas markets.
The diversified health-care company said it earned $3.08 billion, or $1.05 per share, compared with $2.82 billion, or 95 cents per share, in the year-ago period.
Read more at Reuters.com Bonds News
The diversified health-care company said it earned $3.08 billion, or $1.05 per share, compared with $2.82 billion, or 95 cents per share, in the year-ago period.
Read more at Reuters.com Bonds News
No comments:
Post a Comment